Findings from Columbia University Broaden Understanding of Hypertension (Antihypertensive Medication Persistence and Adherence Among Non-hispanic Asian Us Patients With Hypertension and Fee-for-service Medicare Health Insurance): Cardiovascular Diseases and Conditions – Hypertension

2024 APR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Health Policy and Law Daily -- Data detailed on Cardiovascular Diseases and Conditions - Hypertension have been presented. According to news reporting out of New York City, New York, by NewsRx editors, research stated, “Less than 50% of non-Hispanic Asian adults taking antihypertensive medication have controlled blood pressure. We compared non-persistence and low adherence to antihypertensive medication between non-Hispanic Asian and other race/ethnicity groups among US adults >= 66 years who initiated antihypertensive medication between 2011 and 2018 using a 5% random sample of Medicare beneficiaries (non-Hispanic Asian, n = 2,260; non-Hispanic White, n = 56,000; non-Hispanic Black, n = 5,792; Hispanic, n = 4,212; and Other, n = 1,423).”

Our news journalists obtained a quote from the research from Columbia University, “Non-persistence was defined as not having antihypertensive medication available to take in the last 90 of 365 days following treatment initiation. Low adherence was defined as having antihypertensive medication available to take on <80% of the 365 days following initiation. In 2011-2012, 2013-2014, 2015-2016 and 2017-2018, the proportion of non-Hispanic Asian Medicare beneficiaries with non-persistence was 29.1%, 25.6%, 25.4% and 26.7% (p-trend = 0.381), respectively, and the proportion with low adherence was 58.1%, 54.2%, 53.4% and 51.6%, respectively (p-trend = 0.020). In 2017-2018, compared with non-Hispanic Asian beneficiaries, non-persistence was less common among non-Hispanic White beneficiaries (risk ratio 0.74 [95%CI, 0.64-0.85]), non-Hispanic Black beneficiaries (0.80 [95%CI 0.68-0.94]) and those reporting Other race/ethnicity (0.68 [95%CI, 0.54-0.85]) but not among Hispanic beneficiaries (1.04 [95%CI, 0.88-1.23]). Compared to non-Hispanic Asian beneficiaries, non-Hispanic White beneficiaries and beneficiaries reporting Other race/ethnicity were less likely to have low adherence to antihypertensive medication (relative risk 0.78 [95%CI 0.72-0.84] and 0.84 [95%CI 0.74-0.95], respectively); there was no association for non-Hispanic Black or Hispanic beneficiaries.”

According to the news editors, the research concluded: “Non-persistence and low adherence to antihypertensive medication were more common among older non-Hispanic Asian than non-Hispanic White adults.”

For more information on this research see: Antihypertensive Medication Persistence and Adherence Among Non-hispanic Asian Us Patients With Hypertension and Fee-for-service Medicare Health Insurance. PLOS ONE, 2024;19(3). PLOS ONE can be contacted at: Public Library Science, 1160 Battery Street, Ste 100, San Francisco, CA 94111, USA. (Public Library of Science - www.plos.org; PLOS ONE - www.plosone.org)

Our news journalists report that additional information may be obtained by contacting Daichi Shimbo, Columbia University, Irving Med Ctr, Columbia Hypertens Ctr & Lab, New York, NY 10032, United States. Additional authors for this research include Eunhee Choi, Hiroyuki Mizuno, Chloe Fang, Zhixin Wang, Lama Ghazi, Paul Muntner, Matthew T. Mefford and Kristi Reynolds.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1371/journal.pone.0300372. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)